Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 95%
filed 2026-07-07
The filing discloses the completion of a material disposition: on June 30, 2026, Glimpse Group sold all membership interests in Glimpse Learning, LLC (a wholly-owned subsidiary) to Glimpse Learning, Inc. pursuant to a Master Purchase Agreement. The transaction involves transfer of a business unit with associated intellectual property, technology, and contracts, with consideration including equity in the buyer (19.99% interest), ongoing royalty payments, and assumption of liabilities. Item 1.01 and Item 2.01 explicitly document entry into and completion of this material asset disposition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-07
Item 2.01
The filing discloses the completion of a merger on June 30, 2026, in which Aeternum Health LLC merged with and into Shorepower Technologies, Inc., with Shorepower as the surviving entity. The merger resulted in a change of control, with Paul Mann receiving 49 million shares (51% ownership) and 2 million Series B preferred shares with enhanced voting power. The company also changed its name to Aeternum Health, Inc. and shifted its business focus from transportation electrification to critical minerals mining and longevity products. This is a material acquisition/change of control event under Item 2.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-07
Item 7.01
CuriosityStream announced completion of its acquisition of remaining ownership interests in its German operations from SPIEGEL TV and Autentic. The press release explicitly states this transaction "gives CuriosityStream sole ownership of one of its most important international markets" and describes Germany as "the company's largest and most important non-English-speaking market." This is a material acquisition that consolidates control of a key international business segment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-07
Item 1.01
Vivani entered into a definitive Merger Agreement on July 1, 2026, whereby its wholly owned subsidiary Cortigent will merge with ClearOne's merger subsidiary, resulting in Cortigent becoming a wholly owned subsidiary of ClearOne. Vivani shareholders will receive 12,500,000 shares of ClearOne common stock as consideration, subject to financing conditions requiring a $10–15 million capital raise for closing.
View raw filing on EDGAR →
8-K
M&A activity
confidence 94%
filed 2026-07-06
Item 1.01
Unum Life Insurance Company of America entered into a Master Transaction Agreement with Fortitude Reinsurance Company Ltd. to reinsure $3.8 billion of long-term care statutory reserves (26% of total LTC reserves) on a 100% quota share coinsurance basis, with approximately $5.7 billion in assets and cash to be transferred. The transaction is expected to close in 2026 and materially reduces Unum's closed block footprint and risk profile.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
Item 8.01
Incyte announced completion of its acquisition of Vega Therapeutics for $1.25 billion upfront plus up to $750 million in sales milestone payments. The acquisition adds VGA039, a Phase 3 monoclonal antibody for von Willebrand disease, to Incyte's hematology portfolio. This is a material M&A transaction involving a substantial cash outlay and a late-stage clinical asset that strengthens the company's pipeline.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 8.01
USPH announced the acquisition of a twelve-clinic physical therapy practice effective July 1, 2026, acquiring a 67% equity interest for approximately $12 million in annual revenue. This represents a material acquisition that expands the company's footprint from 44 to 45 states and is a core M&A activity requiring 8-K disclosure under Item 1.01 or 2.01, even though filed under Item 8.01.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-07-06
EX-99.1
The press release announces Descartes' acquisition of Drivin, a Latin American last-mile delivery management platform, for approximately US $30 million in upfront cash consideration plus up to US $5 million in performance-based earn-out. This is a material acquisition that expands Descartes' AI-powered logistics capabilities and geographic reach, directly fitting the ma_activity category (Item 1.01 / 2.01 equivalent for foreign issuers).
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 8.01
The filing discloses a merger transaction between Cross Country Healthcare and KL Criss Cross Intermediate, LLC, with a special stockholder meeting scheduled for July 16, 2026, and expected closing in Q3 2026. The Item 8.01 disclosure supplements the proxy statement with supplemental disclosures regarding executive interests, financial analyses, and litigation relating to the merger. This is a material acquisition/change of control event that would significantly affect a reasonable investor's assessment of the registrant.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-06
Item 1.01
Clarivate entered into a Stock and Asset Purchase Agreement to sell its Life Sciences and Healthcare business to an Altaris affiliate for $600 million in aggregate consideration, comprising cash, deferred payments, and a senior note.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 7.01
The filing discloses a previously announced recommended cash acquisition by Ingredion of Tate & Lyle PLC, with the Scheme Document published on July 3, 2026 and shareholder meetings scheduled for July 28, 2026. This represents a material acquisition activity requiring disclosure under Item 1.01 or related M&A provisions, disclosed here under Item 7.01 as a regulatory FD disclosure regarding the Scheme Document and shareholder voting process.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-06
Item 8.01
The filing discloses two material transactions: (1) a 20-year lease agreement with Anthropic generating approximately $19 billion in contracted revenue over the initial term, and (2) the sale of TeraWulf's 50.1% ownership interest in the Abernathy Joint Venture to Fluidstack for approximately $530 million in aggregate consideration. Both transactions are significant capital events that materially affect the company's financial position, revenue visibility, and strategic direction. The Abernathy sale is explicitly a disposition of equity interests, and the Anthropic lease represents a major long-term revenue commitment that would affect investor assessment of the registrant's future cash flows and growth prospects.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-06
Item 7.01
Element Solutions Inc. entered into a definitive Agreement and Plan of Merger on July 6, 2026, whereby Solstice Advanced Materials will acquire Element Solutions in a cash-and-stock transaction valued at approximately $14.5 billion (including assumption of net debt). The transaction structure provides $10.00 cash plus 0.500 Solstice shares per Element share, with expected closing in H1 2027, subject to customary conditions including regulatory and shareholder approvals.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
Item 2.01
Liminatus Pharma completed the acquisition of InnocsAI LLC on July 2, 2026, pursuant to an Amended and Restated Merger Agreement entered into on June 29, 2026. The transaction involved approximately 1.6 billion shares of merger consideration comprising 19.99% common stock and Series A Non-Voting Convertible Preferred Stock, along with registration rights and non-compete agreements.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-07-06
Item 1.01
Meridian3 Industrials Acquisition Corp consummated its IPO on July 1, 2026, raising $201.25 million in gross proceeds through entry into multiple material definitive agreements including underwriting, warrant, registration rights, and private placement agreements.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-06
Item 1.01
Element Solutions Inc entered into an Agreement and Plan of Merger with Solstice Advanced Materials Inc on July 6, 2026, whereby Element Solutions will merge with Solstice subsidiaries in a two-step transaction, with Element Solutions stockholders receiving 0.500 shares of Solstice Common Stock and $10.00 cash per share.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-06
Item 8.01
The filing discloses a material regulatory setback to a pending merger transaction: the New Mexico Public Regulation Commission issued a final order on July 2, 2026, voiding the $400 million PIPE Transaction (equity financing for the Merger) as undertaken without prior NMPRC authorization, imposing a $300,000 aggregate penalty, and requiring a compliance report within 45 days. The NMPRC also stayed the procedural schedule for the Merger Application pending review of the compliance filing. This regulatory action materially affects the consummation and financing of the Merger between TXNM and Blackstone Infrastructure Partners, making it a significant M&A development.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-06
Item 1.01
Crinetics Pharmaceuticals entered into a definitive merger agreement with Vertex Pharmaceuticals on July 6, 2026, under which Vertex will acquire Crinetics for $85.00 per share in cash, representing approximately $10.0 billion in total equity value (or $8.8 billion net of cash). The transaction is expected to close in Q3 2026, subject to regulatory and shareholder approvals, and adds significant commercial and pipeline assets including PALSONIFY and atumelnant with approximately $5 billion peak sales potential to Vertex's portfolio.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-06
EX-99.1
ING announced a strategic investment acquiring approximately 40% stake in Singular Bank, a leading Spanish wealth manager with €19 billion in client invested assets. The transaction represents a material acquisition of a significant ownership stake in an independent financial institution, fitting squarely within the M&A activity category. The press release explicitly describes this as a "strategic investment" and "acquisition of a stake," with closing expected in Q1 2027 subject to regulatory approvals, and CEO commentary emphasizing it as a key strategic move to accelerate growth in Private Banking and Wealth Management.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-06
EX-99.1
ZIM discloses an update on its "previously announced merger agreement with Hapag-Lloyd" and states the company "continues to act in accordance with the agreement and in ongoing collaboration with the relevant state authorities as part of the regulatory review process." This is a material acquisition/merger activity (Item 1.01 or 2.01 equivalent) that would materially affect a reasonable investor's assessment of the registrant's future, even though the update itself is procedural in nature.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-06
Item 8.01
The Company extended the deadline to consummate an initial business combination with Isdera Group Limited following a deposit to the Trust Account, with a registration statement to be filed in connection with the pending merger transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 2.01
CoreCivic completed the sale of two detention facilities (California City Detention Facility and Otay Mesa Detention Center) to the U.S. Department of Homeland Security for an aggregate gross sales price of $1.5 billion on July 2, 2026, with net proceeds of approximately $1.1 billion after taxes and transaction expenses. The company intends to use proceeds to repay debt and pursue growth opportunities. This is a material disposition of significant assets representing a substantial portion of the company's real estate portfolio.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 2.01
Middleby completed a spin-off of its Food Processing business as Midera Food Processing, Inc. on July 6, 2026, distributing 100% of Midera common stock to shareholders on a pro rata basis. Midera began trading on Nasdaq under ticker 'MFP' on July 7, 2026, representing a material change of control and disposition of a significant business segment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 1.01
Midera Food Processing completed its spin-off from The Middleby Corporation on July 6, 2026, with 100% of Midera's outstanding shares distributed pro rata to Middleby stockholders. Midera commenced independent public trading on Nasdaq under ticker 'MFP' on July 7, 2026, governed by multiple definitive agreements including a Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, Intellectual Property Matters Agreement, and Transition Services Agreement.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-07-06
EX-99.1
Rogers Communications has signed an agreement to acquire the remaining 25% ownership stake in Maple Leaf Sports & Entertainment (MLSE) from Kilmer Sports Inc. for C$4.35 billion, increasing Rogers' ownership to 100%. This is a material acquisition transaction that would significantly affect investor assessment of the registrant's capital allocation, strategic direction, and financial position. The transaction is subject to league approvals and expected to close in Q4 2026.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-06
EX-99.1
This news release announces the closing of an acquisition by Cameco and Orano of TEPCO Resources Inc.'s 5% participating interest in the Cigar Lake Joint Venture. The transaction materially increases Cameco's ownership stake in the Cigar Lake uranium mine from approximately 54.5% to 57.418%, a significant increase in a material asset. This is a completed material acquisition that would affect a reasonable investor's assessment of Cameco's asset base and operational control.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-06
The 6-K discloses completion of a redomiciliation and reorganization whereby Marex Group Limited (Bermuda) became the parent holding company of Marex Group plc (UK) through a statutory scheme of arrangement approved by shareholders on May 21, 2026 and the High Court on June 26, 2026, effective July 1, 2026. This constitutes a material change of control and corporate restructuring. The filing also documents New Marex's assumption of all outstanding debt obligations ($1.6 billion in senior notes, subordinated notes, and contingent capital securities) as successor issuer, which is integral to the reorganization transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-06
Item 1.01
RxSight entered into a material License, Collaboration and Development Agreement with Alcon on June 30, 2026, granting Alcon a non-exclusive, worldwide, royalty-bearing license to develop and commercialize light-adjustable versions of Alcon's simultaneous vision intraocular lenses using RxSight's LAL technology. The agreement provides RxSight with a $60 million upfront payment, up to $140 million in additional milestone payments, and 30% royalties on net sales, constituting a significant strategic collaboration that materially affects RxSight's revenue prospects and market position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-06
Item 1.01
Vertex Pharmaceuticals entered into a definitive merger agreement on July 6, 2026, to acquire Crinetics Pharmaceuticals for $85 per share in cash, representing a $10 billion total transaction ($8.8 billion net of cash). The acquisition is expected to be transformative, adding endocrinology assets including PALSONIFY and atumelnant to Vertex's pipeline, with $5 billion+ peak sales opportunity and accretion to non-GAAP operating income by 2029.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
Item 1.01
Ondas Inc. completed the acquisition of DZYNE Technologies, LLC (High Point UAS, LLC) on July 2, 2026, for $875 million in total consideration ($200 million cash and 85 million shares of common stock valued at $675 million). The acquisition materially expands Ondas' autonomous defense platform across persistent intelligence, aerial security, counter-UAS, and autonomous effects, with projected 2027 revenue exceeding $300 million and 80%+ revenue CAGR through 2028.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 1.01
Maison Solutions' subsidiaries entered into an Asset Purchase Agreement on July 1, 2026, to divest two store locations (San Gabriel and Monrovia) and related assets for $4.5 million as part of a strategic realignment to eliminate loss-generating operations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-06
Item 3.02
Big Digital Energy entered into a 50/50 joint venture with 10NetZero and signed a letter of intent to acquire a 50% interest in a power-ready industrial site in Hood County, Texas for AI datacenter development, with planned capital deployment of approximately $3.56 billion across three development tracks. This material acquisition of real property and infrastructure assets represents a substantial strategic transaction that will significantly expand the company's operational capacity and asset base.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-06
The filing discloses a definitive merger agreement entered into on July 6, 2026, whereby Solstice Advanced Materials will acquire Element Solutions in a cash-and-stock transaction valued at approximately $14.5 billion. The joint press release and investor presentation detail the strategic rationale, transaction structure ($10.00 cash plus 0.500 Solstice shares per Element share), financing arrangements, and expected closing in H1 2027. This is a material acquisition creating an industry-leading advanced materials platform with significant strategic and financial implications.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 1.01
Maison Solutions Inc. entered into and closed an Equity Purchase Agreement on July 2, 2026, to sell its 91.67% equity interest in Super HK of El Monte, Inc. to DNL Management Inc. This material disposition of a subsidiary represents a substantial portion of the Company's assets and was completed simultaneously with execution.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-06
The 6-K discloses entry into a Stock Purchase Agreement on July 2, 2026, whereby Baiya International Group Inc. sold all of its equity interests in Starfish Technology-FZE to Shengshi International Group Inc. for US$1,000,000 in cash. This constitutes a material disposition of a subsidiary or operating entity, falling squarely within the ma_activity category (Item 1.02 / 2.01 equivalent). The transaction is material to a reasonable investor as it represents a complete divestiture of an asset previously acquired under a prior agreement dated September 19, 2025.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-06
The filing discloses entry into an Agreement and Plan of Merger on July 6, 2026, whereby Solstice Advanced Materials Inc. will acquire Element Solutions Inc. through a two-step merger structure. The Merger Agreement has been unanimously approved by both boards and contemplates issuance of Solstice common stock as merger consideration (0.500 shares per Element Solutions share plus $10 cash). This is a material acquisition transaction requiring Item 1.01 disclosure and triggering Rule 425 written communications obligations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 1.01
This disclosure describes entry into a Share Exchange Agreement on June 30, 2026, whereby PCMC acquires all issued and outstanding shares of Physicians Capital Management Corporation in exchange for approximately 93.5 million shares of PCMC stock (common and preferred), representing approximately 80% of PCMC's fully-diluted outstanding shares post-closing. This constitutes a material acquisition and change of control transaction, with Ivie (Physicians' sole equity holder) gaining control of PCMC's board and Conrad Ivie becoming CEO. The transaction will cause PCMC to cease being a shell company and fundamentally transforms the company's business to healthcare real estate development.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 2.01
The filing discloses the completion of a material asset disposition: the sale of the Hyatt Regency Savannah hotel for $158.0 million in cash on June 30, 2026, pursuant to an Agreement of Purchase and Sale dated May 15, 2026. This is a completed disposition of a significant hotel property by indirect subsidiaries of Ashford Hospitality Trust, triggering Item 2.01 disclosure and accompanied by pro forma financial statements showing the removal of the asset and its operating results. The transaction is material to investors assessing the registrant's portfolio and financial position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 1.01
Prestige Consumer Healthcare completed the acquisition of LaCorium Health Australia and related entities on July 1, 2026, for approximately $150 million in cash. LaCorium is a leader in Australian therapeutic skin care with approximately $40 million in annual revenue. The company entered into an amendment to its Term Loan Credit Agreement permitting an additional $95 million borrowing to finance the acquisition.
View raw filing on EDGAR →
8-K
M&A activity
confidence 93%
filed 2026-07-06
Item 2.01
Envirotech Vehicles, Inc. completed its acquisition of Azio AI Corporation on July 2, 2026, pursuant to an Amended and Restated Agreement and Plan of Merger. The transaction involved a two-step merger structure resulting in Azio AI becoming a wholly owned subsidiary, with consideration consisting of 2,460,351 shares of common stock (capped at 19.9% of outstanding shares), 973,450 shares of Series A Preferred Stock, and assumed convertible notes.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 1.01
Professional Diversity Network, Inc. entered into and completed a Stock Purchase Agreement on July 2–3, 2026, to sell 100% of its ownership interests in two subsidiaries (NAPW, Inc. and IAW, Inc.) to MEB Holding LLC for $150,000, representing a material disposition of subsidiary equity interests.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 8.01
On July 3, 2026, Dorchester Minerals entered into a non-taxable contribution and exchange agreement to acquire mineral and royalty interests totaling approximately 3,100 net royalty acres across five counties in the Williston Basin, North Dakota, in exchange for 850,000 common units, with expected closing on July 31, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-06
Verde Renewables entered into a Master Commercialization and Collaboration Agreement with Ergon Asphalt & Emulsions, Inc. on July 1, 2026, establishing a 10-year strategic partnership under which Verde will supply engineered biochar and carbon credit monetization services, while Ergon commits to developing and marketing biochar-containing products. The filing emphasizes this as Verde's "transition from technology validation into commercial execution" with a major industry player (the largest U.S. asphalt supplier), including non-binding annual target volumes, revenue-sharing arrangements, and royalty payments. While structured as a collaboration rather than a traditional M&A transaction, the scope, duration, and strategic significance—coupled with the amendment to the Biochar Solutions supply agreement to facilitate this arrangement—constitute a material commercial arrangement that would affect a reasonable investor's assessment of Verde's business prospects and revenue potential.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
The filing discloses completion of an acquisition of substantially all assets of Plant Engineering Services, Inc. by Cemtrex's subsidiary AIS on July 1, 2026, for $3.5 million in cash plus up to $1.75 million in earnout consideration. Item 2.01 explicitly addresses "Completion of Acquisition or Disposition of Assets," and the press release confirms this is a material strategic transaction adding engineering capabilities to the Industrial Services segment and expanding into automotive and defense markets.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-06
Item 5.01
Greater Cannabis Company underwent a change of control on June 29, 2026, when the Controlling Shareholder acquired Series A and Series B Preferred Stock, resulting in approximately 96.62% voting control through privately negotiated transactions documented in the Series A and Series B Share Purchase Agreements.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-06
Item 1.01
This disclosure concerns an amendment to an Equity Purchase Agreement for the sale of Dagley Insurance (a subsidiary acquired in 2021) by Fathom Holdings to D6 Holdings and Nathan Dagley. The amendment modifies material payment terms ($3.0 million purchase price restructured into installments), cancels 278,000 shares, and redefines ongoing service obligations through May 2028. While technically an amendment rather than the original transaction, it materially affects the terms and enforceability of a disposition and would impact investor assessment of the company's capital structure and contingent obligations.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-06
Item 3.02
Solaris Energy Infrastructure completed the acquisition of Global Energy Services Alliance, Inc. on July 1, 2026, pursuant to a Merger Agreement, funded by approximately $55 million in cash and the issuance of approximately 2.88 million Class A shares. The acquisition is expected to strengthen in-house power generation capabilities and be accretive to earnings and free cash flow per share.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-06
Item 7.01
Neolara Corp. announced entry into a non-binding letter of intent for a potential acquisition of a Hong Kong-based AI image restoration company, representing the company's "initial step into the AI technology services sector as part of its broader strategic diversification initiative." Although the LOI is non-binding and subject to numerous conditions, the announcement of a material acquisition target and the company's stated strategic pivot constitute a reportable M&A activity event under Item 1.01 framework, even at the LOI stage.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-06
Item 8.01
Edgemode entered into a non-binding term sheet on July 1, 2026 regarding the sale of its interest in land sites in Spain to a third-party purchaser for data center development. Although the term sheet is non-binding and subject to due diligence and definitive documentation, the disclosure of a material disposition of real property assets—structured as a share purchase of entities holding the land—constitutes a material M&A activity event. The company also retained a joint venture option, indicating a significant strategic transaction. The materiality is evident from the detailed disclosure of the transaction structure, exclusivity period, and conditions precedent.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-06
Item 7.01
Splash Beverage Group entered into an exclusive global licensing agreement with Argent BioPharma Limited to acquire worldwide rights to CannEpil®, a cannabinoid-based epilepsy therapeutic. The transaction includes $5.5 million in newly issued preferred equity consideration, a $1 million strategic investment commitment, and represents a material acquisition of intellectual property and commercial rights that aligns with the company's stated strategic transformation toward a cannabinoid biopharmaceutical platform. This constitutes a material acquisition activity under Item 1.01/2.01 framework.
View raw filing on EDGAR →